» Articles » PMID: 25032099

Transplant Options for Patients with Type 2 Diabetes and Chronic Kidney Disease

Overview
Specialty General Surgery
Date 2014 Jul 18
PMID 25032099
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic kidney disease (CKD) has become a real epidemic around the world, mainly due to ageing and diabetic nephropathy. Although diabetic nephropathy due to type 1 diabetes mellitus (T1DM) has been studied more extensively, the vast majority of the diabetic CKD patients suffer from type 2 diabetes mellitus (T2DM). Renal transplantation has been established as a first line treatment for diabetic nephropathy unless there are major contraindications and provides not only a better quality of life, but also a significant survival advantage over dialysis. However, T2DM patients are less likely to be referred for renal transplantation as they are usually older, obese and present significant comorbidities. As pre-emptive renal transplantation presents a clear survival advantage over dialysis, all T2DM patients with CKD should be referred for early evaluation by a transplant center. The transplant center should have enough time in order to examine their eligibility focusing on special issues related with diabetic nephropathy and explore the best options for each patient. Living donor kidney transplantation should always be considered as the first line treatment. Otherwise, the patient should be listed for deceased donor kidney transplantation. Recent progress in transplantation medicine has improved the "transplant menu" for T2DM patients with diabetic nephropathy and there is an ongoing discussion about the place of simultaneous pancreas kidney (SPK) transplantation in well selected patients. The initial hesitations about the different pathophysiology of T2DM have been forgotten due to the almost similar short- and long-term results with T1DM patients. However, there is still a long way and a lot of ethical and logistical issues before establishing SPK transplantation as an ordinary treatment for T2DM patients. In addition recent advances in bariatric surgery may offer new options for severely obese T2DM patients with CKD. Nevertheless, the existing data for T2DM patients with advanced CKD are rather scarce and bariatric surgery should not be considered as a cure for diabetic nephropathy, but only as a bridge for renal transplantation.

Citing Articles

Predicted Indirectly Recognizable T-cell Epitope (PIRCHE) Load Correlates With Rejection Events After Simultaneous Pancreas-Kidney Transplantation.

Parajuli S, Niemann M, Dale B, Hidalgo L, Gupta G, Kaufman D Transplant Direct. 2025; 11(3):e1764.

PMID: 39936136 PMC: 11810031. DOI: 10.1097/TXD.0000000000001764.


Multi-Centre UK Analysis of Simultaneous Pancreas and Kidney (SPK) Transplant in Recipients With Type 2 Diabetes Mellitus.

Owen R, Carr H, Counter C, Tingle S, Thompson E, Manas D Transpl Int. 2024; 36:11792.

PMID: 38370534 PMC: 10869449. DOI: 10.3389/ti.2023.11792.


Immunosuppressive Agents-Effects on the Cardiovascular System and Selected Metabolic Aspects: A Review.

Opalka B, Zolnierczuk M, Grabowska M J Clin Med. 2023; 12(21).

PMID: 37959400 PMC: 10647341. DOI: 10.3390/jcm12216935.


Comparison of Outcomes and Survival of Two Cohorts of Patients with Simultaneous Pancreas-Kidney Transplantation: A Retrospective Cohort Study in a Latin American Hospital.

Martin-Gonzalez I, Barrera-Lozano L, Villada-Ochoa O, Ramirez-Arbelaez J, Lopez-Pompey N, Palacios D Biomed Res Int. 2023; 2023:2734072.

PMID: 37359049 PMC: 10287523. DOI: 10.1155/2023/2734072.


A comparative study of pancreas transplantation between type 1 and 2 diabetes mellitus.

Shyr B, Shyr B, Chen S, Loong C, Shyr Y, Wang S Hepatobiliary Surg Nutr. 2021; 10(4):443-453.

PMID: 34430523 PMC: 8351016. DOI: 10.21037/hbsn-19-422.


References
1.
Light J, Sasaki T, Currier C, Barhyte D . Successful long-term kidney-pancreas transplants regardless of C-peptide status or race. Transplantation. 2001; 71(1):152-4. DOI: 10.1097/00007890-200101150-00025. View

2.
Ludwig B, Ludwig S, Steffen A, Saeger H, Bornstein S . Islet versus pancreas transplantation in type 1 diabetes: competitive or complementary?. Curr Diab Rep. 2010; 10(6):506-11. DOI: 10.1007/s11892-010-0146-y. View

3.
Meier-Kriesche H, Arndorfer J, Kaplan B . The impact of body mass index on renal transplant outcomes: a significant independent risk factor for graft failure and patient death. Transplantation. 2002; 73(1):70-4. DOI: 10.1097/00007890-200201150-00013. View

4.
Chakkera H, Bodner J, Heilman R, Mulligan D, Moss A, Mekeel K . Outcomes after simultaneous pancreas and kidney transplantation and the discriminative ability of the C-peptide measurement pretransplant among type 1 and type 2 diabetes mellitus. Transplant Proc. 2010; 42(7):2650-2. PMC: 3060052. DOI: 10.1016/j.transproceed.2010.04.065. View

5.
Gruessner R, Sutherland D . Simultaneous kidney and segmental pancreas transplants from living related donors - the first two successful cases. Transplantation. 1996; 61(8):1265-8. DOI: 10.1097/00007890-199604270-00025. View